Sanofi/GSK: Recombinant Protein

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 1 Trial

Phase 2: 2 Trials

  • NCT04537208
    United States of America
  • NCT04762680
    Australia, France, Honduras, Kenya, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America

Phase 3: 3 Trials


This vaccine is not yet approved.

Registered Trials